Radiation proctitis (RP) is a significant unmet medical need, with no well-established standard of care. Access is actively seeking marketing partners globally for ProctiGard™. Access Pharmaceuticals president and
This satisfies the necessary patient numbers proposed for the trial. Following from the positive results achieved from the interim analysis of the serum Insulin-like Growth Factor-I (sIGF-I) data
Medivir CEO Maris Hartmanis said: "The recommendation is one additional step in the global strategy that our partner Janssen has for simeprevir, to offer a new and efficacious
According to the recommendation, Bexsero should be routinely used in infants from two months of age to help protect against meningococcal serogroup B (meningitis B). The implementation will
NCCN ORP vice president Dr Diane E. Paul noted it is grateful to collaborate with Boehringer Ingelheim on this ground-breaking research initiative. "The research supported by this grant
The patent (No. 8,663,987) covers BrainStorm’s proprietary stem cells induced to secrete elevated levels of neurotrophic factors for the treatment of neurodegenerative diseases. The neurotrophic factors secreted by
Concordia CEO Mark Thompson noted that the acquisition of Donnatal represents an important advancement in the execution of the company’s legacy product strategy, providing substantial and sustainable revenue
A manufacturing agreement that covers all aspects of the production of the encapsulated live cells has been signed by Nuvilex and Austrianova. An initial payment has been made
MCT-485 is a very small noncoding double stranded RNA (dsRNA) molecule which has demonstrated a unique cytotoxic, oncolytic, and immune stimulating activity in in vitro models of hepatocellular
The results are being presented today in an oral session at the 9th European Breast Cancer Conference (EBCC) in Glasgow, Scotland at 9:45 AM local time. The ENCHANT-1
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.